Odysight.ai Inc.

Odysight.ai Inc. (ODYS) reported FY 2025 revenues of $3.0M, down 24% YoY from $3.96M in 2024, primarily due to full derecognition of a $1.7M contract liability from a Fortune 500 medical customer, offset partially by $1.2M from PdM/CBM vision-based platforms versus $0.9M prior year. Gross profit fell 25% to $871K from $1.16M, with cost of revenues declining proportionally to $2.1M. Operating loss widened 45% to -$18.1M, driven by R&D expenses up 40% to $9.6M, sales/marketing up 91% to $2.3M, and G&A up 27% to $7.0M amid hiring, Nasdaq uplisting, and stock compensation. Net loss increased to -$17.0M from -$11.8M, with basic/diluted EPS at -$1. Balance sheet strengthened with cash/cash equivalents at $25.7M (up from prior), total assets $29.0M, equity $25.4M. Operating cash use was -$13.7M, offset by $21.1M financing from public offering. Backlog dipped to $13.8M from $15M. Investments in Industry 4.0 PdM/CBM signal growth potential in aerospace/defense, despite losses and customer concentration risks.

Key Takeaways